reference/16679334

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16679334

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1178
issn	0140-6736
issueIdentifier	9568
pageRange	1169-1178
publicationName	Lancet (London, England)
startingPage	1169
bibliographicCitation	Clotet B, Bellos N, Molina JM, Cooper D, Goffard JC, Lazzarin A, Wöhrmann A, Katlama C, Wilkin T, Haubrich R, Cohen C, Farthing C, Jayaweera D, Markowitz M, Ruane P, Spinosa-Guzman S, Lefebvre E; POWER 1 and 2 study groups. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. Lancet. 2007 Apr 07;369(9568):1169–78. doi: 10.1016/s0140-6736(07)60497-8. PMID: 17416261.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_610e7f67c713f1e089390ac5b8980818 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5372ba07407fcac576308382670fbc16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_920fe524f3740daa58cf86c6e7c18768 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c048054a0ae7b39e6fa28b51eb827591 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dca39327dce8fd41aefd3bdaf8eb4529 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05cf643ddddb0b1ba3aeeda239f983f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cc3c1466cf9eb75562fa7c15e9b2c05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a61a95013ba601351842a73fccdb9ee7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff2122621771c47483229ec197ce5033 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9694d167e5a04525c32bce77bc858c76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5a31891f3352d9e77ecd8132b45a487 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c15f0d806c74b84ac15d3a0c6da8d2c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ceae3dbde93c3567b887b7ec04e4078 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c31ae1a27f3f38bcd61406d13b46e875 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e75660fc527569c87f2fbc9329de0d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ea719cfe61f8a1f3758afdf74faeca2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_342c650a9871b4ab9928264b5d693c0e
date	2007-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0140-6736%2807%2960497-8 https://pubmed.ncbi.nlm.nih.gov/17416261
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
discusses	http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0026300 http://id.nlm.nih.gov/mesh/M0028918 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0461844
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019438Q000627 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D015497 http://id.nlm.nih.gov/mesh/D013449Q000627 http://id.nlm.nih.gov/mesh/D017320Q000627 http://id.nlm.nih.gov/mesh/D012367Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019438Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D012367Q000187 http://id.nlm.nih.gov/mesh/D000069454 http://id.nlm.nih.gov/mesh/D013449Q000009 http://id.nlm.nih.gov/mesh/D017320Q000009 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017320Q000008 http://id.nlm.nih.gov/mesh/D019438Q000009 http://id.nlm.nih.gov/mesh/D013449Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130199 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID213039 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127632504 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135754805 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033

Total number of triples: 70.